Leprosy, also known as Hansen's Disease, is one of the most ancient diseases known to humans. Although the World Health Organization declared leprosy to be under control in many previously endemic countries, most experts agree that current approaches to treating the disease are not sufficient to eliminate the disease as a public health problem. Currently, 1.6 billion people are considered at risk of exposure to leprosy, while over 800 new cases occur every day.
The Infectious Disease Research Institute (IDRI) has been awarded a $1 million grant from Renaissance Health Service Corporation (RHSC) and its Research and Data Institute, as the founding sponsor of IDRI's efforts to eliminate the disease of leprosy. The funding will support IDRI's development of a diagnostic to identify early infection of the disease, as well as an effective vaccine to provide long-term protection to those who are most at risk. These new tools, along with currently available drugs to treat people who are infected, will be the basis of the leprosy elimination campaign.Â
Â
"We are very pleased to be supporting IDRI in its critically important and novel efforts toward the elimination of leprosy in the world," says  Nancy E. Hostetler, senior vice president of corporate and public affairs for RHSC. "Although leprosy is widely known, it is also widely ignored. We believe it is tragic that this disease continues to affect millions of people, and take pride in being the founding sponsor of the campaign aimed at finally eliminating it."
Although currently drug therapy during the early stages of the disease reduces its progression and spread, poor diagnostics and lack of access to regular health care often mean that many people who develop leprosy are treated too late, after disfigurement and transmission to others has already occurred. IDRI is nearing the development and licensure of a novel, inexpensive and effective diagnostic that will detect early stages of the disease in a person before they develop clinical symptoms.
Additionally, current leprosy programs are focused solely on detection and treatmentnot prevention. Development of a successful vaccine is critical to leprosy elimination efforts. Toward this end, IDRI has identified the largest panel of M. leprae antigens that are relevant to human disease, which will lead to the components necessary for an effective vaccine. IDRI has also refined a system for testing vaccine candidates and is working with partners, such as the American Leprosy Mission and national health centers around the world, to develop and assess vaccine efficacy.
"We are extremely thankful for Renaissance's vision and support in providing critical funding to develop a novel diagnostic tool, and the launch of an aggressive leprosy elimination program," says Steven G. Reed, PhD, IDRI founder, president, and CSO. "The long-term vision of this partnership is to eradicate leprosy from the 24 countries in which it remains endemic, eliminating the disease once and for all."
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.